| Multidisciplinary management of gastric cancer. | |
| | |
MedLine Citation:
|
PMID: 20827183 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE OF REVIEW: The treatment of gastric cancer has been rapidly evolving with the emergence of new cytotoxic drugs and targeted biologic agents. The purpose of this review is to provide an update in the treatment of localized and metastatic gastric cancer. RECENT FINDINGS: Although the overall incidence of gastric cancer has been declining in the United States, the disease continues to be a devastating problem worldwide. Complete surgical resection offers the chance of cure for localized gastric cancer. However, local and distant recurrences are common. Adjuvant chemoradiation with 5-fluorouracil/leucovorin significantly improves disease-free survival and overall survival as demonstrated by the US Intergroup INT-116 study. Most recently, the UK Medical Research Council Adjuvant Gastric trial showed survival benefit with perioperative chemotherapy. Preoperative chemotherapy and chemoradiation have also been explored in several small randomized studies with encouraging results. However, this approach needs to be further confirmed in a large randomized phase III study. Finally, novel molecular targeting agents have been incorporated into the multimodality treatment and shown promising response rate and progression-free survival. SUMMARY: Gastric cancer remains one of the most clinically challenging cancers among all gastrointestinal malignancies. Mutimodality approach clearly offers survival benefit over surgery alone. In the United States, preoperative chemoradiation or postoperative adjuvant chemoradiation is widely practiced in major centers. |
| | |
Authors:
|
Yixing Jiang; Jaffer A Ajani |
Related Documents
:
|
17581713 - Sporadic gastric neurofibroma underneath early cancer: mdct gastrography and histologic... 8819223 - Can endoscopic biopsy specimens be used for reliable laurén classification of gastric ... 12119563 - Molecular cloning and characterization of osr1 on human chromosome 2p24. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current opinion in gastroenterology Volume: 26 ISSN: 1531-7056 ISO Abbreviation: Curr. Opin. Gastroenterol. Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-10-15 Completed Date: 2011-01-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8506887 Medline TA: Curr Opin Gastroenterol Country: United States |
Other Details:
|
Languages: eng Pagination: 640-6 Citation Subset: IM |
Affiliation:
|
Hematology/Oncology Division, Department of Medicine, Penn State Hershey Medical Center, Hershey, Pennsylvania 17033, USA. yjiang@hmc.psu.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Chemotherapy, Adjuvant Clinical Trials as Topic Drug Therapy, Combination Humans Neoadjuvant Therapy Neoplasm Metastasis Radiotherapy, Adjuvant Stomach Neoplasms / drug therapy*, radiotherapy*, surgery* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Helicobacter pylori infection and current clinical areas of contention.
Next Document: Natural killer cells and tumor control.